Maze Therapeutics, Inc. (MAZE)
NASDAQ·Healthcare·Biotechnology
$24.05
+0.83%
Mkt Cap $1.33B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (11 analysts)
$59.43
Range $46.00 – $97.00
Implied Upside
+147.1%
Consensus $59.43 vs current $24.05
NASDAQ·Healthcare·Biotechnology
$24.05
+0.83%
Mkt Cap $1.33B
Buy
8
Hold
0
Sell
0
Price Target (11 analysts)
$59.43
Range $46.00 – $97.00
+147.1%
Consensus $59.43 vs current $24.05